Resultados de la búsqueda 51-60 of 5738 for ☀[광고텔레:SEOGOT] 구글상위광고대행 010인증삽니다 구글백링크 010인증대행 구글상단업체 상단광고☀

  1. Cirugía - Ensayos clínicos - Mayo Clinic

    This study aims to investigate the utility of using plasma DNA methylation to detect measurable residual disease or early recurrence/progression of patients ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Probiotics Preventing Immune Checkpoint Inhibitor-Induced Colitis · To evaluate the safety of multi-strain probiotic blend in cancer patients receiving ICIs. · To ...

  3. Ensayos clínicos - Centro Pediátrico de Mayo Clinic

    Selumetinib is a drug that works by blocking some enzymes that low grade glioma tumor cells need for their growth. This results in killing tumor cells. Drugs ...

  4. Fluorescence-guided surgery for brain cancers - Mayo Clinic

    This surgical technique can help surgeons find and remove cancerous tissue in real-time during surgeries.

  5. Neurología - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to develop a biorepository of blood samples from cancer patients participating in the Gemini (IRB 19-006717) protocol. These ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to compare the effect of adding nivolumab to the usual chemotherapy (cisplatin or carboplatin with gemcitabine) versus the ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer.

  8. Sobre - Mayo Clinic

    A tumor may be cancerous, also called malignant, or noncancerous, also called benign. Brain tumor surgery may be the first treatment for a brain tumor. Some ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...